Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis

Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis

Objectives: This study determined the diagnostic and prognostic usefulness of hepatocyte growth factor (HGF) in light chain and transthyretin cardiac amyloidosis. Background: Delays in diagnosis of cardiac amyloidosis are common, usually resulting from nonspecific findings on clinical examination an...

Full description

Bibliographic Details
Main Authors: Kathleen W. Zhang, MD, Jennifer Miao, MD, Joshua D. Mitchell, MD, Jose Alvarez-Cardona, MD, Kelsey Tomasek, BS, Yan Ru Su, MD, Mary Gordon, RN, R. Frank Cornell, MD, Daniel J. Lenihan, MD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:JACC. CardioOncology
Subjects:
biomarkers
cardiac amyloidosis
hepatocyte growth factor
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320300090

Internet

http://www.sciencedirect.com/science/article/pii/S2666087320300090

Similar Items